“…Factors which predict the length of CR include B symptoms (Cosset et al, 1984;Tubiana et al, 1985;Longo et al, 1986), stage (Haybittle et al, 1985;Sutcliffe et al, 1984;Horwich et al, 1986), histology (Haybittle et al, 1985;Sutcliffe et al, 1984;Specht et al, 1987), number of disease sites (Cosset et al, 1984;Tubiana et al, 1985;Horwich et al, 1986), age (Sutcliffe et al, 1984;Tubiana et al, 1985;Longo et al, 1986), male sex (Tubiana et al, 1985;Specht et al, 1987), erythrocyte sedimentation rate (ESR) (Haybittle et al, 1985;Tubiana et al, 1985), tumour burden (Specht et al, 1987), number of extranodal sites (Longo et al, 1986), the presence of bulky mediastinal disease (Hoppe et al, 1982), time to achieve CR (Longo et al, 1986) and drug dose intensity (Pillai et al, 1985).…”